News
« back
Tickets for the first installment of the Opera Rara series now on sale
Add date: Tuesday, 20 December 2011
 From tomorrow (the 21st of December), tickets for the first 2012 instalment of the Opera Rara series – a concert version of Catone in Utica by Antonio Vivaldi – will be available from www.eventim.pl. The concert will be the Polish opening performance of the masterpiece, prepared especially for the Opera Rara series by the Theater an der Wien.
From 2nd January, tickets will also be on sale at the InfoKrakow City Information Point at ul. św. Jana 2 in Krakow.
Antonio Vivaldi's Catone in Utica is a dramma per musica in 3 acts (only 2 of the acts survive though). The piece is based on Pietr Metastasio's libretto, which premiered at the Venice Teatro Filarmonico in 1737. Characters include the dictator Cesare (soprano), an advocate of Republican principles Catone (tenor), Numidian prince Arbace (soprano), a widow of Pompey defeated by Caesar (soprano), her lover Fulvio (alto) and Katon's daugther - Marcia (alto). Following the premiere, two years later, the opera was staged in Venice and then, in 1740, in Graz. A record of the contemporary version of the opera was prepared by Claudio Scimone in 1984. In 1998, Jean Claude Malgiore presented a new reconstruction of the piece (leaving out acts II and III, with act I being a so-called pasticcio), which he recorded in 2001. Modo Antiquo, along with Federico Maria Sardelli, will now bring to Krakow Acts II and III - an original version of the piece.
PRICE LIST:
Zone I – 180 PLN regular ticket, 120 PLN discount ticket
Zone II – 150 PLN regular ticket, 100 PLN discount ticket
Discount tickets: school and university students under 26 years old, seniors, retired persons, pensioners, disabled people.
Free admission: children under 10 years old (free tickets must be placed by e-mail: rezerwacje@biurofestiwalowe.pl before You buy tickets).
Before you buy tickets please read Krakow Festival Office tickets sales regulations. Purchase will be treated as regulations approval.
Other news:
|
